Jul 10, 2017 | CEO Update
There is an alarming difference between the novice one-size-fits-all stem cell treatment and the decades of experience and knowledge performed and owned by Regenexx. It is critical to be a knowledgeable consumer and business owner to not only avoid subpar treatment...
Jun 27, 2017 | CEO Update
The decision to have orthopedic surgery should be heavily considered as it is impossible to cut into the body and not damage tissue. The only question is whether the possible benefits outweigh the harm. If you have a less invasive procedure that is a lower risk with...
Jun 21, 2017 | CEO Update
We track patients in a Registry which tracks pain and function scores and outcome over time, and guides research and treatment decisions…but we love hearing directly from our pateints! This Regenexx SD knee update made us smile! Readers of this blog will remember...
Jun 16, 2017 | CEO Update
One of the largest elective procedure spends in any company health plan is orthopedic surgery. On average, 20-40% of an employer’s overall health care costs are associated with orthopedic care. That’s an overwhelming expense considering over 58% of...
Jun 12, 2017 | CEO Update
We are intervening on 80% of patients who are surgical candidates for 17% of the cost of surgery with better outcomes. from the desk of Jason Hellickson I would like to walk you through exactly how we have accomplished this with self-insured employers and demonstrate...
